{"id":10999,"date":"2026-10-25T06:34:53","date_gmt":"2026-10-25T10:34:53","guid":{"rendered":"https:\/\/www.inflation.us\/news\/?p=10999"},"modified":"2026-10-25T06:34:55","modified_gmt":"2026-10-25T10:34:55","slug":"medicure-vs-hydrograph-clean-power-most-important-chart","status":"publish","type":"post","link":"https:\/\/www.inflation.us\/news\/articles\/medicure-vs-hydrograph-clean-power-most-important-chart\/","title":{"rendered":"Medicure vs. Hydrograph Clean Power: Most Important Chart"},"content":{"rendered":"\n<div style=\"width:100%; max-width:650px; margin:0 auto; padding:0 10px; box-sizing:border-box; font-family:Arial,Helvetica,sans-serif; font-size:14px; line-height:1.6; color:#333333; -webkit-text-size-adjust:100%; -ms-text-size-adjust:100%; text-size-adjust:100%; mso-line-height-rule:exactly;\">\n\n  <p style=\"margin:0 0 16px; padding:0; font-family:Arial,Helvetica,sans-serif; font-size:14px; line-height:1.6;\">\n    The <strong><span style=\"color:#2980b9;\">most important<\/span> chart<\/strong> to understand that <strong>Medicure (TSXV: MPH)<\/strong> is a <strong><span style=\"color:#2980b9;\">real<\/span> company<\/strong> that is a <span style=\"color:#2980b9;\"><strong>100% sure thing<\/strong><\/span> to <span style=\"color:#27ae60;\"><strong>gain another 1,000%<\/strong><\/span> over the next twelve months vs. <strong>Hydrograph Clean Power (CSE: HG)<\/strong> being a <span style=\"color:#2980b9;\"><strong>100% sure thing<\/strong><\/span> to <span style=\"color:#e74c3c;\"><strong>decline another 90%<\/strong><\/span> over the next twelve months is the following chart of <strong>R&amp;D expenditures<\/strong>.\n    \n    <strong>MPH<\/strong> was able to <strong><span style=\"color:#e74c3c;\">skip past<\/span> Phase 1 and Phase 2 trials<\/strong> for <strong>MC-1<\/strong> due to the <span style=\"color:#27ae60;\"><strong>massive investments<\/strong><\/span> previously made into the drug from 1997 through 2008 and now they are in <strong>Phase 3 trials<\/strong> and will <span style=\"color:#27ae60;\"><strong>receive<\/strong><\/span> an <strong>FDA Priority Review Voucher<\/strong> after receiving <strong>FDA <span style=\"color:#2980b9;\">approval<\/span><\/strong> that they will be able to sell for well over <span style=\"color:#27ae60;\"><strong>US$200 million<\/strong><\/span>:\n  <\/p>\n\n  <p style=\"margin:0 0 16px; padding:0; text-align:center;\">\n    <img decoding=\"async\"\n      src=\"https:\/\/www.inflation.us\/news\/wp-content\/uploads\/2026\/10\/medicurevshydrographrdexpenses.jpg\"\n      alt=\"Medicure vs. Hydrograph Clean Power R&#038;D Expenditures\"\n      width=\"600\"\n      style=\"display:block; width:100%; max-width:600px; height:auto; margin:0 auto; border:0;\"\n    \/>\n  <\/p>\n\n  <p style=\"margin:0 0 12px; padding:0; font-family:Arial,Helvetica,sans-serif; font-size:8px; line-height:1.4; color:#666666;\">\n    Past performance is not indicative of future results. NIA is not an investment advisor and does not provide investment advice. Always do your own research and make your own investment decisions. NIA&rsquo;s President has purchased 87,000 shares of MPH and intends to buy more shares. This communication is for informational and educational purposes only.\n  <\/p>\n\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The most important chart to understand that Medicure (TSXV: MPH) is a real company that is a 100% sure thing to gain another 1,000% over the next twelve months vs. Hydrograph Clean Power (CSE: HG) being a 100% sure thing to decline another 90% over the next twelve months is the following chart of R&amp;D [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":11001,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[365,154,414,8],"class_list":["post-10999","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","tag-biotech","tag-hg","tag-mph","tag-technology"],"_links":{"self":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts\/10999","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/comments?post=10999"}],"version-history":[{"count":1,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts\/10999\/revisions"}],"predecessor-version":[{"id":11002,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/posts\/10999\/revisions\/11002"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/media\/11001"}],"wp:attachment":[{"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/media?parent=10999"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/categories?post=10999"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.inflation.us\/news\/wp-json\/wp\/v2\/tags?post=10999"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}